One of Jamaica's foremost public health experts, Professor Peter Figueroa, is confident the development regarding the delayed roll-out of the AstraZeneca/Oxford COVID-19 vaccine in South Africa will not negatively impact the World Health Organization's (WHO) authorisation of the jab for use in countries that are part of the COVAX facility.
